The elevated Caspase-1 activity further supports the hypothesis that the NLRP3 inflammasome hyperactivation in the intestinal mucosa of IBD patients might be sustained by XO hyperexpression and activity in the same cell compartment. This evidence concerns the gene NLRP3 and inflammatory bowel disease.